DocDollars

Portola Pharmaceuticals, LLC

CA · United States · Reporting entity ID 100000246827

Total reported 2019–2025
$8.84M
#532 of 2,960 reporting companies — 0% of all reported industry payments
$3.02M in general payments across 12,758 records, plus $5.82M in research funding across 1,318 records.

How it breaks down

General payments $3,022,928
Research funding $5,815,114

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Portola Pharmaceuticals, LLC reported $8.84M to US doctors and teaching hospitals from 2019 to 2025, ranking #532 of 2,960 reporting companies. 66% of that was research funding and 34% general payments such as consulting, speaking, food and travel. 12,758 general payment records and 1,318 research records were filed.

Common questions about Portola Pharmaceuticals, LLC

How much has Portola Pharmaceuticals, LLC paid US doctors?

Portola Pharmaceuticals, LLC reported $8,838,042 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,022,928 in general payments, $5,815,114 in research funding.

How does Portola Pharmaceuticals, LLC rank among drug and device companies?

It ranks #532 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Portola Pharmaceuticals, LLC mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.